InsiderClue
Stocks · Health care · Surgical & Medical Instruments & Apparatus

TriSalus Life Sciences, Inc.

TLSI Clue Score59
United States Fiscal year ends December CIK 0001826667 Results filed 6 Aug 2026
Add to watchlist

What the insiders did Net buying

Individual transactions

53
Insider
Date
Role
Action
Shares
Price
Amount
Jennifer Stevens
5 Oct 2026
Chief Regulatory Officer
Sell
316
$4.39
$1.39K
Richard Marshak
5 Oct 2026
Chief Commercial Officer
Sell
325
$4.39
$1.43K
Bryan F. Cox
5 Oct 2026
Chief of Research
Sell
296
$4.39
$1.30K
Gary B. Gordon
15 May 2026
Director
Buy
10,000
$2.46
$24.60K
David Patience
15 May 2026
Chief Financial Officer
Buy
7,100
$2.43
$17.25K
Mary T Szela
15 May 2026
CEO and President
Buy
39,682
$2.59
$102.78K
Michael P Stansky
15 May 2026
Director
Buy indirect
200,000
$2.50
$500.00K
Michael P Stansky
15 May 2026
Director
Buy
410,000
$2.50
$1.03M
Mats Wahlstrom
15 May 2026
Director
Buy
60,000
$2.53
$151.80K
Richard Marshak
15 May 2026
Chief Commercial Officer
Sell
543
$2.67
$1.45K
Mary T Szela
17 Mar 2026
CEO and President
Sell
15,944
$3.85
$61.38K
Jennifer Stevens
16 Mar 2026
Chief Regulatory Officer
Sell
774
$4.12
$3.19K
Richard Marshak
16 Mar 2026
Chief Commercial Officer
Sell
419
$4.12
$1.73K
Bryan F. Cox
16 Mar 2026
Chief of Research
Sell
579
$4.12
$2.39K
Jodi Devlin
16 Mar 2026
Chief of Clinical Operations
Sell
273
$4.12
$1.12K
Jennifer Stevens
12 Mar 2026
Chief Regulatory Officer
Sell
1,552
$4.09
$6.35K
Richard Marshak
12 Mar 2026
Chief Commercial Officer
Sell
1,589
$4.09
$6.50K
Bryan F. Cox
12 Mar 2026
Chief of Research
Sell
1,467
$4.09
$6.00K
Jodi Devlin
12 Mar 2026
Chief of Clinical Operations
Sell
1,772
$4.09
$7.25K
Mary T Szela
11 Mar 2026
CEO and President
Sell
4,358
$4.13
$18.00K
Jennifer Stevens
11 Mar 2026
Chief Regulatory Officer
Sell
1,204
$4.13
$4.97K
Richard Marshak
11 Mar 2026
Chief Commercial Officer
Sell
1,449
$4.13
$5.98K
Bryan F. Cox
11 Mar 2026
Chief of Research
Sell
1,138
$4.13
$4.70K
Jodi Devlin
11 Mar 2026
Chief of Clinical Operations
Sell
1,162
$4.13
$4.80K
Michael P Stansky
23 Feb 2026
Director
Buy indirect
117,198
$4.10
$480.51K
Michael P Stansky
23 Feb 2026
Director
Buy
243,900
$4.10
$999.99K
Mary T Szela
23 Feb 2026
CEO and President
Buy
30,487
$4.10
$125.00K
William Valle
23 Feb 2026
Director
Buy
30,487
$4.10
$125.00K
Gary B. Gordon
23 Feb 2026
Director
Buy
9,756
$4.10
$40.00K
David Patience
23 Feb 2026
Chief Financial Officer
Buy
3,657
$4.10
$14.99K
Jennifer Stevens
19 May 2025
Chief Regulatory Officer
Sell
8,704
$5.18
$45.09K
Richard Marshak
19 May 2025
Chief Commercial Officer
Sell
6,597
$5.18
$34.17K
Jodi Devlin
19 May 2025
Chief of Clinical Operations
Sell
4,764
$5.18
$24.68K
Bryan F. Cox
19 May 2025
Chief of Research
Sell
4,764
$5.18
$24.68K
James Emmett Young
5 Feb 2025
Chief Financial Officer
Buy indirect
6,000
$5.65
$33.90K
Mary T Szela
30 Jan 2025
CEO and President
Buy
5,010
$5.28
$26.45K
Mary T Szela
29 Jan 2025
CEO and President
Buy
5,030
$5.03
$25.30K
Sean Murphy
28 Jan 2025
Chief Manuf, Strategy&Bus Dev.
Buy indirect
15,000
$5.17
$77.55K
Mary T Szela
28 Jan 2025
CEO and President
Buy
4,716
$5.12
$24.15K
James Emmett Young
27 Jan 2025
Chief Financial Officer
Buy indirect
24,000
$5.40
$129.60K
Sean Murphy
27 Jan 2025
Chief Manuf, Strategy&Bus Dev.
Buy indirect
15,000
$5.31
$79.65K
Mary T Szela
27 Jan 2025
CEO and President
Buy
4,826
$5.42
$26.16K
Equity AB Frankenius
17 Dec 2024
10% owner
Buy
62,972
$3.97
$250.00K
Arjun JJ Desai
10 Dec 2024
Director
Sell
30,000
$3.69
$110.70K
Mats Wahlstrom
22 Nov 2024
Director
Buy
5,000
$4.55
$22.75K
Mats Wahlstrom
21 Nov 2024
Director
Buy
8,687
$4.44
$38.57K
Mats Wahlstrom
20 Nov 2024
Director
Buy
2,040
$4.16
$8.49K
Bryan F. Cox
5 Oct 2024
Chief Scientific & Manufact.
Sell
314
$4.44
$1.39K
Mary T Szela
13 Sep 2024
CEO and President
Buy
6,000
$5.00
$30.00K
Mary T Szela
13 Sep 2024
CEO and President
Buy
1,295
$4.83
$6.25K
Mary T Szela
12 Sep 2024
CEO and President
Buy
7,520
$5.20
$39.10K
Mary T Szela
10 Sep 2024
CEO and President
Buy
5,000
$4.97
$24.85K
George Kelly Martin
28 Aug 2024
Director
Sell indirect
9
$5.50
$49.50

What was left out

Form 4 filings counted 126
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 2
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 25
Transactions with no price 0
Shares from compensation/vesting 10,802,789
History held since 28 Dec 2020